CORVIA MEDICAL
Corvia Medical is a medical device company, focuses on developing structural heart devices for the treatment of heart failure. The company develops InterAtrial Shunt Device (IASD), a transcatheter device designed to treat diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). It was founded in 2009 and headquartered in Andover, Massachusetts.
CORVIA MEDICAL
Industry:
Biopharma Health Care Medical Device
Founded:
2009-01-01
Address:
Andover, Massachusetts, United States
Country:
United States
Website Url:
http://www.corviamedical.com
Total Employee:
11+
Status:
Active
Contact:
978-654-6123
Email Addresses:
[email protected]
Total Funding:
119.41 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Enable Injections
Enable Injections designs and produces on-body delivery systems that allow patients to self-administer large amounts of medication.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
NuPulseCV
NuPulse specializes in developing technology designed to treat patients with heart failure.
P3 Health Partners
P3 Health Partners is a patient-centered, physician-led and population health-focused healthcare company.
Current Advisors List
Current Employees Featured
Founder
Investors List
General Catalyst
General Catalyst investment in Series D - Corvia Medical
Lumira Ventures
Lumira Ventures investment in Series D - Corvia Medical
Third Rock Ventures
Third Rock Ventures investment in Series D - Corvia Medical
Accelmed
Accelmed investment in Series D - Corvia Medical
Third Rock Ventures
Third Rock Ventures investment in Series C - Corvia Medical
Lumira Ventures
Lumira Ventures investment in Series C - Corvia Medical
General Catalyst
General Catalyst investment in Series C - Corvia Medical
Official Site Inspections
http://www.corviamedical.com Semrush global rank: 5.14 M Semrush visits lastest month: 1.57 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Corvia Medical"
About Us - Corvia Medical
Corvia Medical’s leadership team is comprised of professionals who share a passion and commitment to transform the standard of care for heart failure treatment. Each member of the …See details»
Treatment for Symptomatic Heart Failure - Corvia® Atrial Shunt
The Corvia® Atrial Shunt is designed to reduce symptoms associated with heart failure (HF), reduce HF hospitalizations, and improve quality of life.See details»
Corvia Medical - Crunchbase Company Profile & Funding
Corvia Medical may be growing as indicated by a significant financial investment, which is a strong indicator of investor confidence and potential for expansion. The company has secured …See details»
Investors - Corvia Medical
Corvia Medical is funded by Accelmed, Third Rock Ventures, General Catalyst Partners, Lumira Capital, Edwards Lifesciences, and an undisclosed strategic investor. Their support enables …See details»
Corvia Medical, Inc. Information - RocketReach
Corvia Medical, Inc. is a Medical Equipment Manufacturing, Medical Devices & Equipment, and Biopharma company located in Tewksbury, Massachusetts with $23.4 million in revenue and …See details»
Working At Corvia Medical: Company Overview and Culture - Zippia
Find out what it's like to work at Corvia Medical. See what kind of people work at Corvia Medical, career paths working at Corvia Medical, company culture, salaries, employee political …See details»
Corvia Medical, Inc. Company Overview, Contact Details
Find, capture, and sync contact data to your CRM and sales tools in one click. What is Corvia Medical, Inc. 's official website and social media links? Corvia Medical, Inc. 's official website is …See details»
Corvia Medical Achieves CE Certification for Atrial Shunt Under …
Dec 20, 2024 Commercial validation in Europe parallels ongoing RESPONDER-HF clinical trial TEWKSBURY, MA – December 20, 2024 – Corvia Medical, Inc., a company dedicated to …See details»
Corvia Medical - Overview, News & Similar companies - ZoomInfo
View Corvia Medical (www.corviamedical.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Corvia Medical | VentureRadar
Corvia Medical, Inc., formerly DC Devices Inc., is a privately held medical device company dedicated to revolutionizing the treatment of heart failure with first-in-class structural heart …See details»
Find a Center - Corvia Medical
Use the map below to find a center in your area that offers Corvia Atrial Shunt Therapy. If you don’t see a center listed in your area, please email us at [email protected] as new …See details»
Healthcare Professionals - Corvia Medical
CORVIA® ATRIAL SHUNT SYSTEM The Corvia Atrial Shunt is a novel, minimally invasive cardiac implant for symptomatic heart failure (HF) patients with an EF≥40%. Major step …See details»
Corvia Medical - CipherBio
Explore Corvia Medical's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
How it works - Corvia Medical
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a …See details»
Corvia Medical Achieves CE Certification for Atrial Shunt
Dec 23, 2024 Commercial validation in Europe parallels ongoing RESPONDER-HF clinical trial TEWKSBURY, Mass., Dec. 20, 2024 /PRNewswire/ -- Corvia Medical, Inc., a company …See details»
corviamedical.com - Treatment for Symptomatic Hear... - Corvia …
Corviamedical.com. The Corvia® Atrial Shunt is designed to reduce symptoms associated with heart failure (HF), reduce HF hospitalizations, and improv...See details»
Newsroom - Corvia Medical
Corvia Medical Releases Two-Year Clinical Trial Results Confirming Sustained Benefit and Safety of its Atrial Shunt in Heart Failure PatientsSee details»
Corvia Medical Announces Enrollment of First Patients in Pivotal …
ANAHEIM, CA – November 14, 2017 — Corvia Medical, Inc., a privately-held medical device company that developed a first-in-class transcatheter structural heart device to treat heart …See details»
Corvia Medical Announces Three-Year Clinical Trial Results …
TEWKSBURY, MA – October 25, 2024 – Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced impressive three-year results …See details»
Corvia Patient Information Guide - corviamedical.com
Wie heeft een atriale shunt nodig? Atriale shunts worden gebruikt voor de behandeling van patiënten met chronisch hartfalen die symptomen hebben als gevolg van een hoge druk in het …See details»